The National Cancer Institute (NCI) recently decided to partner with the Multiple Myeloma Research Foundation (MMRF) to integrate genomic information, clinical data and oncology medicine.

To honor World Heart Day, the American Heart Association (AHA) highlighted the importance of the patient and provider relationship as physicians encourage patients to manage their heart failure.

To recognize Blood Cancer Awareness Month, Amgen Inc. recently honored patients who have been affected by blood cancer as well as scientists, researchers, nurses, physicians and caregivers.

The National Organization for Rare Disorders (NORD), an independent nonprofit organization that represents 30 million U.S. residents with rare diseases, recently received federal funds to help stop the Zika virus.

More than 700 Tina’s Wish supporters recently gathered at the Museum of Natural History to raise a total of $1.4 million that is dedicated to early detection ovarian cancer research.

Chairmen and ranking members of the Senate Health Committee and House Energy and Commerce Committee recently stated that they are making progress in reaching a bipartisan deal for the 21st Century Cures legislation.

The U.S. Senate has unanimously voted to lengthen the Rare Pediatric Disease Priority Review Voucher (PRV) Program, speeding up treatments for 15 million children living with rare diseases.

The U.S. Food and Drug Administration (FDA) recently approved a Biologics License Application (BLA) for a GlaxoSmithKline plc (GSK) sirukumab that is designed to treat rheumatoid arthritis.

Chembio Diagnostics Inc., a leader in point-of-care (POC) diagnostic tests for infectious diseases, recently received a contract from the Centers for Disease Control and Prevention (CDC) for surveillance diagnostic assays for Zika, dengue and chikungunya.

Global Genes recently launched its fifth annual RARE Tribute to Champions of Hope and Patient Advocacy Summit, raising more than $1.4 million meant to fund rare disease awareness, education and grant programs.

The Leukemia and Lymphoma Society (LLS) and WealthEngine (WE), the top supplier of predictive analytics, marketing and audience development services, recently partnered to raise funds for blood cancer research.

The National Organization for Rare Disorders (NORD) recently joined over 300 organizations on Capitol Hill in the Rally for Medical Research Hill Day on Sept. 22, urging leaders to raise funds for the National Institutes of Health (NIH).

Sue Dubman, a health care and informatics researcher who has Parkinson’s disease, recently wrote an article in the 'Journal of Parkinson’s Disease' to explain that she wants to share her information to further scientific research.

Mental Illness Awareness Week runs Oct. 2-8, highlighting mental health challenges in addition to honoring publications about bipolar disorder, anxiety and depression.

Boehringer Ingelheim and ViraTherapeutics recently formed a long-term partnership to create a next-generation oncolytic virus therapy platform and evaluate a top candidate Vesicular Stomatitis Virus (VSV) glycoprotein (GP).

Leaders with the U.S. Food and Drug Administration (FDA) recently expanded its approval of Ilaris to include three new indications of rare diseases for adult as well as pediatric patients.

Amgen recently announced that its research has revealed new data for Imlygic (talimogene laherparepvec) to treat melanoma and metastatic colorectal cancer, stating that the information will be presented at the European Society for Medical Oncology 2016 Congress.

Millions of people receiving advanced tax credits under the Affordable Care Act either did not file the correct form with the IRS or did not file taxes at all, according to numbers crunched by an expert in health care policy.

Officials with the U.S. Food and Drug Administration recently warned consumers that some homeopathic gels and tablets designed for teething could be risky for children and infants.

The U.S. Food and Drug Administration (FDA) recently approved the world’s first hybrid insulin delivery system, a decision that the American Diabetes Association (ADA) supports.